The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.08
Bid: 0.075
Ask: 0.085
Change: 0.005 (6.67%)
Spread: 0.01 (13.333%)
Open: 0.0775
High: 0.08
Low: 0.0775
Prev. Close: 0.075
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Recommencement of Share Buyback Programme

13 Dec 2023 07:01

RNS Number : 5551W
Reabold Resources PLC
13 December 2023
 

13 December 2023

 

Reabold Resources plc

 

("Reabold" or the "Company")

 

Recommencement of Share Buyback Programme

Total Voting Rights

 

Reabold Resources plc, the oil & gas investing company with a diversified portfolio of exploration, appraisal and development projects, is pleased to announce the restart of its share buyback programme, under new terms (the "Programme").

On 31 October 2022, Reabold announced its intention to commence a share buyback programme with the intention to return £4 million of excess cash to shareholders upon receipt of £9.5 million of deferred net proceeds to Reabold from Shell, relating to the sale of the Victory asset. The Company accelerated this return with an initial £750,000 buyback programme that commenced in April 2023 and has returned £156,154 to shareholders to date.

Reabold has now received £5.2 million of the deferred consideration from Shell in respect of the sale of the Victory asset, and is recommencing the Programme with up to a further £593,846 to be returned to shareholders.

Reabold's Board evaluates many investment opportunities consistent with its investing policy and believes that the current market value of the Company's Ordinary Shares makes the buyback an appropriate use of capital. The maximum quantum of the Programme has been set by the Board after having considered the current capital position and future capital needs of the Company, such that it retains financial flexibility whilst maintaining an efficient balance sheet.

The Board will keep the Programme under review to ensure that it continues as an efficient and effective means of generating value for Reabold shareholders. While the Company has launched the Programme, there is no certainty on the volume of shares that may be acquired, nor any certainty on the pace and quantum of acquisitions.

Stifel Nicolaus Europe Limited ("Stifel"), will continue to conduct the Programme and repurchase Ordinary Shares on Reabold's behalf, for a maximum amount of £593,846 worth of Ordinary Shares. During any closed periods of the Company, the buyback agreement will grant Stifel the authority to enact purchases of Ordinary Shares and make trading decisions concerning the timing of the purchases under the Programme independently of the Company. The purpose of the Programme is to reduce the issued ordinary share capital of Reabold.

The Programme will be conducted within certain pre-set parameters in accordance with the Company's general authority granted to the Company at its General Meeting on 29 June 2023 and will not exceed acquisitions of more than 2,263,532,572 Ordinary Shares. The average daily volume figure acquired under the Programme will be no more than 25% of the average daily volume traded in the calendar month preceding this announcement, thus the maximum daily volume limit will be 16,414,069 Ordinary Shares.

Any Ordinary Shares acquired under the Programme shall be at a maximum price (excluding expenses) of the higher of: (i) 10% above the average of the middle market quotations for an Ordinary Share as derived from the AIM Section of the Daily Official List of the London Stock Exchange for the five business days before the date on which the contract for the purchase is made; and (ii) an amount equal to the higher of the price of the last independent trade and current independent bid as derived from the London Stock Exchange trading system.

It is intended that the Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 (as in force in the UK by virtue of the European Union (Withdrawal) Act 2018 and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) (the "Regulation"), the Commission Delegated Regulation (EU) 2016/1052 (as in force in the UK by virtue of the European Union (Withdrawal) Act 2018 and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) (the "Delegated Regulation"). 

The Programme is expected to continue until the Company's General Meeting to be held on 10 January 2024, at which point the Programme will be reviewed.

Any market repurchase of Ordinary Shares will be announced no later than 7:30 a.m. on the business day following the calendar day on which the repurchase occurred. 

Total voting rights

Following the admission to trading on AIM of the 486,486,487 new Ordinary Shares issued to LNEnergy pursuant to the exercise of the second option as announced on 11 December 2023, the total issued share capital of the Company consists of 10,474,685,207 Ordinary Shares. The Company holds 111,572,837 Ordinary Shares in treasury. Accordingly, the total number of voting rights in the Company is 10,363,112,370 and this is the figure that may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Ends

 

 

For further information, contact:

 

Reabold Resources plc

Sachin Oza

Stephen Williams

 

c/o Camarco

+44 (0) 20 3757 4980

 

 

Strand Hanson Limited - Nominated & Financial Adviser

James Spinney

James Dance

Rob Patrick

 

Stifel Nicolaus Europe Limited - Joint Broker

Callum Stewart

Simon Mensley

Ashton Clanfield

 

Cavendish - Joint Broker

Barney Hayward

 

+44 (0) 20 7409 3494

 

 

 

 

+44 (0) 20 7710 7600

 

 

 

 +44 (0) 20 7220 0500

Camarco

Billy Clegg

Rebecca Waterworth

Sam Morris

 

+44 (0) 20 3757 4980

 

 

Notes to Editors

 

Reabold Resources plc has a diversified portfolio of exploration, appraisal and development oil & gas projects. Reabold's strategy is to invest in low-risk, near-term projects which it considers to have significant valuation uplift potential, with a clear monetisation plan, where receipt of such proceeds will be returned to shareholders and re-invested into further growth projects. This strategy is illustrated by the recent sale of the undeveloped Victory gas field to Shell, the proceeds of which are being returned to shareholders and re-invested.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPGAPPUPWGRP
Date   Source Headline
28th Jun 201311:41 amRNSFinal Results
12th Jun 20132:22 pmRNSResult of AGM
17th May 20137:00 amRNSPosting of Shareholder Circular
21st Dec 20124:56 pmRNSFinal Results
21st Dec 20124:53 pmRNSRestoration to Trading, etc.
21st Dec 20124:52 pmRNSHalf Yearly Report
19th Dec 201212:52 pmRNSResult of General Meeting etc.
3rd Dec 20125:48 pmRNSNotice of General Meeting
17th Aug 20125:00 pmRNSChange of Adviser
23rd Jul 201212:17 pmRNSAppointment of Administrators
20th Jul 201212:56 pmRNSNotice of Intention to Appoint Administrators
16th Jul 20127:00 amRNSSale of bChannels Ltd and Second2 Ltd
26th Jun 201210:00 amRNSSuspension - Adventis Group Plc
26th Jun 201210:00 amRNSStatement re. Suspension
19th Jun 201210:43 amRNSFurther Update on sale of Technology division
13th Jun 20121:01 pmRNSUpdate on proposed sale of Technology division
10th May 20127:00 amRNSUpdate
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
11th Jan 20127:00 amRNSDisposal
7th Dec 20117:00 amRNSDisposal
28th Sep 20117:00 amRNSHalf Yearly Report
19th Sep 20117:00 amRNSOrderly wind down of Adventis Health
30th Jun 20116:15 pmRNSResult of AGM
23rd Jun 20117:00 amRNSNPA Appeal Upheld
6th Jun 201111:14 amRNSPosting of Annual Report and Notice of AGM
27th May 20117:00 amRNSPreliminary Results - year ended 31 December 2010
12th May 20112:54 pmRNSDirectorate Change
10th May 20117:00 amRNSTrading Update
20th Apr 201112:40 pmRNSDirectorate Change
4th Apr 20119:56 amRNSDirectorate Change
23rd Mar 20112:55 pmRNSNPA - termination of recognition
4th Mar 201111:38 amRNSChange of Registered Office
14th Feb 20117:00 amRNSDirectorate Change
27th Jan 20117:00 amRNSTrading Update
9th Nov 20107:00 amRNSDirectorate Change
15th Sep 20107:00 amRNSDirector Declaration
15th Sep 20107:00 amRNSInterim Results - half year ended 30 June 2010
18th Aug 20107:00 amRNSTrading Update
13th Aug 201012:25 pmRNSDirector/PDMR Shareholding
19th May 20104:01 pmRNSResult of AGM
19th May 20107:00 amRNSAGM Statement
5th May 201010:55 amRNSAnnual Report Published
30th Apr 20107:00 amRNSSettlement of Litigation
29th Apr 20101:30 pmRNSre RNS announcement
29th Apr 20107:00 amRNSSettlement of Litigation
29th Mar 20104:44 pmRNSDirectors' Dealings and Options Exercise
24th Mar 20107:00 amRNSFinal Results
2nd Feb 20107:00 amRNSAcquisition
29th Jan 20107:00 amRNSTrading Statement
16th Dec 200912:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.